Abstract:
Halallan Thoyibban is a powerful product label that enhances the wholesomeness, quality, and integrity of any product. Halal is not just limited to eating and drinking but also encompasses earning a livelihood, dress code, and interactions with others. Therefore, the concept of halal extends beyond religious practices. Halal products promise safety, hygiene, quality, and efficacy as products have to meet the highest quality standards and rigorous regulations. These products are not only permitted for Muslims but also for non-Muslims to use. Biotechnology has emerged as the new frontier in pharmaceuticals ranging from the production of insulin using bacteria, gene editing, and genetically modified organisms. It has seen significant advancements in recent years that enables the production of high-quality and effective drugs. Growing with the latest advances
in pharmaceuticals, many questions arise on whether these modern pharmaceuticals still abide by the promises of Halallan thoyibban and do what is called permissible and legitimate and is not contrary to God’s instructions. It is imperative to address the unspoken issues related to halal medicine as they have the potential to cause significant problems in the future. This review discusses the latest advancement of biotechnology in pharmaceuticals and how these pharmaceutical products comply with the promises of Halallan thoyibban. As there is a growing need for halal pharmaceuticals globally, this venture has to explicitly ensure that pharmaceutical products meet the highest standards of safety, efficacy, and quality.
